Piperis, C.; Marathonitis, A.; Anastasiou, A.; Theofilis, P.; Mourouzis, K.; Giannakodimos, A.; Tryfou, E.; Oikonomou, E.; Siasos, G.; Tousoulis, D.
Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action. Biomedicines 2024, 12, 2314.
https://doi.org/10.3390/biomedicines12102314
AMA Style
Piperis C, Marathonitis A, Anastasiou A, Theofilis P, Mourouzis K, Giannakodimos A, Tryfou E, Oikonomou E, Siasos G, Tousoulis D.
Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action. Biomedicines. 2024; 12(10):2314.
https://doi.org/10.3390/biomedicines12102314
Chicago/Turabian Style
Piperis, Christos, Anastasios Marathonitis, Artemis Anastasiou, Panagiotis Theofilis, Konstantinos Mourouzis, Alexios Giannakodimos, Elsi Tryfou, Evangelos Oikonomou, Gerasimos Siasos, and Dimitris Tousoulis.
2024. "Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action" Biomedicines 12, no. 10: 2314.
https://doi.org/10.3390/biomedicines12102314
APA Style
Piperis, C., Marathonitis, A., Anastasiou, A., Theofilis, P., Mourouzis, K., Giannakodimos, A., Tryfou, E., Oikonomou, E., Siasos, G., & Tousoulis, D.
(2024). Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action. Biomedicines, 12(10), 2314.
https://doi.org/10.3390/biomedicines12102314
